Yang B G, Yu X P, Chen F, Lyu S Z, Li Q, He J Q, Yuan F
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing 100029, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
To compare the long-term clinical outcomes of consecutive patients treated with coronary artery bypass grafting (CABG) or percutaneous coronary intervention(PCI) with drug-eluting stents (DES) for bifurcation lesions in unprotected left main coronary artery (ULMCA). A total of 663 consecutively patients with unprotected left main bifurcation disease (defined as stenosis≥50%) who received either drug-eluting stents (DES) implantation (=316) or underwent CABG (=347) between January 2003 and July 2009 in Beijing Anzhen Hospital were enrolled retrospectively in this study.The endpoints of the study were death, repeat revascularization, myocardial infarction (MI), stroke, the composite of cardiac death, MI or stroke and MACCE (major adverse cardiac and cerebrovascular events, the composite of cardiac death, MI, stroke or repeat revascularization). To reduce the bias between two compared groups , our study applid propensity score matching by logistic regression.Cumulative survival rate was calculated by Kaplan-Meier method.Multiple regression analyses, hazard ratio() and 95% were tested by Cox proportional hazard models with the CABG group as the reference category. The median follow-up was 7.2 years (interquartile range 5.1 to 8.3 years) in the overall patients.Unadjusted analysis showed that MACCE rate (PCI 44.5% vs. CABG 45.7%, =0.036), the rate of repeat revascularization (PCI 33.7% vs. CABG 19.5%, <0.001), the composite rate of serious outcomes (cardiac death, MI or stroke) (PCI 20.4% vs. CABG 34.3%, =0.032), stroke rate (PCI 3.7% vs. CABG 23.5%, <0.001) were significantly different for patients undergoing PCI or CABG. Death rate (PCI 13.0% vs. CABG 18.9%, =0.12) and MI rate (PCI 11.3% vs. CABG 6.1%, =0.108) were similar between PCI and CABG group.After adjusting covariates with multivariate Cox hazard regression model, there was no significant difference in rates of death (=0.286), MI(=0.165) and the composite rate of serious outcomes (cardiac death, MI or stroke) (=0.305) between the two groups. Patients in PCI group suffered significant higher rates of MACCE(=0.011), mainly driven by the significant higher rates of repeat revascularization(=2.46, 95% 1.662-3.642, <0.001). However, stroke rate was still significantly higher in CABG group than in PCI group(=0.001)after multivariate adjusting. After propensity score matching (PSM), there was no more significant difference for all covariates in the matched cohorts (202 pairs). Further PSM analysis showed that overall findings were consistent with multivariate Cox hazard regression model except for MI (PCI 12.7% vs. CABG 3.8%, =0.039). During a follow-up up to 8.3 years, the survival rate is similar between the PCI and the CABG group in patients with unprotected left main bifurcation disease.The rate of repeat revascularization is significantly higher whereas stroke rate is significantly lower in the PCI group compared to CABG group.After propensity score matching, PCI group not only had a significant higher rate of repeat revascularization, but also had significantly higher risk of MI in the matched cohorts; while they did not seem to translate into any disparity of mortality in ULMCA bifurcation disease patients.Accordingly, PCI for ULMCA disease can be used as a reasonable treatment option alternative to CABG.
比较连续接受冠状动脉旁路移植术(CABG)或经皮冠状动脉介入治疗(PCI)并使用药物洗脱支架(DES)治疗无保护左主干冠状动脉(ULMCA)分叉病变患者的长期临床结局。本研究回顾性纳入了2003年1月至2009年7月在北京安贞医院连续663例接受药物洗脱支架植入(n = 316)或接受CABG(n = 347)治疗的无保护左主干分叉病变(定义为狭窄≥50%)患者。研究终点为死亡、再次血运重建、心肌梗死(MI)、卒中、心源性死亡、MI或卒中的复合终点以及主要不良心脑血管事件(MACCE,心源性死亡、MI、卒中或再次血运重建的复合终点)。为减少两组间的偏差,本研究采用逻辑回归进行倾向评分匹配。采用Kaplan-Meier法计算累积生存率。以CABG组为参照类别,通过Cox比例风险模型进行多元回归分析、检验风险比(HR)及95%置信区间。总体患者的中位随访时间为7.2年(四分位间距5.1至8.3年)。未调整分析显示,接受PCI或CABG治疗的患者在MACCE发生率(PCI 44.5% vs. CABG 45.7%,P = 0.036)、再次血运重建率(PCI 33.7% vs. CABG 19.5%,P < 0.001)、严重结局(心源性死亡、MI或卒中)复合率(PCI 20.4% vs. CABG 34.3%,P = 0.032)、卒中发生率(PCI 3.7% vs. CABG 23.5%,P < 0.001)方面存在显著差异。PCI组和CABG组的死亡率(PCI 13.0% vs. CABG 18.9%,P = 0.12)和MI发生率(PCI 11.3% vs. CABG 6.1%,P = 0.108)相似。经多变量Cox风险回归模型调整协变量后,两组在死亡率(P = 0.286)、MI发生率(P = 0.165)和严重结局(心源性死亡、MI或卒中)复合率(P = 0.305)方面无显著差异。PCI组患者的MACCE发生率显著更高(P = 0.011),主要是由于再次血运重建率显著更高(HR = 2.46,95%CI 1.662 - 3.642,P < 0.001)。然而,多变量调整后CABG组的卒中发生率仍显著高于PCI组(P = 0.001)。倾向评分匹配(PSM)后,匹配队列(202对)中所有协变量均无显著差异。进一步的PSM分析显示,除MI外(PCI 12.7% vs. CABG 3.8%,P = 0.039),总体结果与多变量Cox风险回归模型一致。在长达8.3年的随访期间,无保护左主干分叉病变患者中PCI组和CABG组的生存率相似。与CABG组相比,PCI组的再次血运重建率显著更高,而卒中发生率显著更低。倾向评分匹配后,PCI组不仅再次血运重建率显著更高,而且在匹配队列中MI风险也显著更高;而在ULMCA分叉病变患者中,这些差异似乎并未转化为死亡率的差异。因此,对于ULMCA疾病,PCI可作为CABG的合理替代治疗选择。